Inventor · disambiguated record
Paul Szymanski
Also filed as: SZYMANSKI PAUL
3 granted patents·10 pending applications·10 citations·filing 2006–2024
65Inventor score
Files with4D MOLECULAR THERAPEUTICS INC7SCHERING AG2SCHERING AKTIENGESELLACHAFT2BAYER SCHERING PHARMA AG1LIGHT DAVID1
Top patents by PatentIndex Score
13 records- 0195US11802278B2Codon optimized GLA genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2022·Granted Oct 31, 2023·3 cites·10 claims
- 0293US11198858B2Codon optimized GLA genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2021·Granted Dec 14, 2021·2 cites·23 claims
- 0388US11766489B2Adeno-associated virus variant capsids and use for inhibiting angiogenesis4D MOLECULAR THERAPEUTICS INC·Filed 2018·Granted Sep 26, 2023·5 cites·33 claims
- 0479US2024018498A1Codon optimized gla genes and uses thereof4D MOLECULAR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0573US2025057987A1Compositions and Methods for Treatment of Ocular Disease Associated with Angiogenesis4D MOLECULAR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0671US2024226336A9Compositions and Methods for Treatment of Ocular Disease Associated with Angiogenesis4D MOLECULAR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0764US2024335560A1Adeno-associated virus variant capsids and use for inhibiting angiogenesis4D MOLECULAR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0849US2011020925A1New modulating molecules for an improved regulated expression systemBAYER SCHERING PHARMA AG·Filed 2008·Application pending·0 cites
- 0945US2007179113A1GM-CSF gene therapy for Crohn's disease using an improved regulated expression systemSCHERING AKTIENGESELLACHAFT·Filed 2007·Application pending·0 cites
- 1042US2008076729A1Interferon-beta gene therapy using an improved, regulated expression systemSCHERING AKTIENGESELLACHAFT·Filed 2007·Application pending·0 cites
- 1141US2006281703A1Treatment of disease using an improved regulated expression systemSCHERING AG·Filed 2006·Application pending·0 cites
- 1241US2006292609A1Interferon-beta gene therapy using an improved, regulated expression systemSCHERING AG·Filed 2006·Application pending·0 cites
- 1335US2013259806A1Dimeric molecular complexes with free cysteine residues and conjugates thereofLIGHT DAVID·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Szymanski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →